Insider Transactions in Q3 2024 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 25
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
8,744
+16.42%
|
-
|
Jul 25
2024
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
2,917
-20.05%
|
$221,692
$76.51 P/Share
|
Jul 01
2024
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-2.03%
|
$136,000
$68.63 P/Share
|